Major outcomes at the 12-month follow-up, following DAS28 cut-off points and ACR remission criteria, in the follow-up cohort
| Disease activity status (T12) | No (%) of patients (total 481) |
| ACR remission | 73 (15.2%) |
| DAS28 status | |
| Remission (≤2.6) | 165 (34.3%) |
| Low disease activity (2.6–3.2) | 88 (18.3%) |
| Moderate disease activity (3.2–5.1) | 170 (35.3%) |
| High disease activity (>5.1) | 58 (12.1%) |
ACR, American College of Rheumatology; DAS28, disease activity score in 28 joints; T12, 12-month follow-up.